Cadonilimab Plus Lenvatinib Proves Active in Platinum-Pretreated, Advanced Endometrial Cancer.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 68
- By:
- Publication type:
- Article
Works matching IS 23745347 AND DT 2025 AND VI 26 AND IP 6
Results: 17
1
2
Nivolumab Yields High Clinical CR Rates Allowing for Surgery Omission in dMMR/MSI-H Endometrial Cancer.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 67
- By:
- Publication type:
- Article
3
Pembrolizumab/Olaparib Regimen Improves PFS in BRCA Wild-Type Epithelial Ovarian Cancer.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 66
- By:
- Publication type:
- Article
4
Updated Data Support Mirvetuximab Soravtansine as SOC for FRα+ Platinum-Resistant Ovarian Cancer.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 64
- By:
- Publication type:
- Article
5
NADOFARAGENE FIRADENOVEC IS EFFECTIVE WITH BENEFICIAL DOSING SCHEDULE IN REAL WORLD FOR BCG-UNRESPONSIVE NMIBC.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 56
- By:
- Publication type:
- Article
6
Redefining Translational Research and China's Impact on US Drug Development.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 53
- By:
- Publication type:
- Article
7
How AI Is Revolutionizing Decision-Making in Health Care.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 52
- By:
- Publication type:
- Article
8
New EBMT Machine Learning Model Outperforms Available Tools in Predicting Transplant Risk in Myelofibrosis.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 51
- By:
- Publication type:
- Article
9
THE ROLE OF LIQUID BIOPSIES in Precision Approaches for Breast Cancer Therapy.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 46
- By:
- Publication type:
- Article
10
ABLE-32 Looks to Expand the Use of Nadofaragene Firadenovec Into Intermediate-Risk NMIBC.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 44
- By:
- Publication type:
- Article
11
Preliminary Casdozokitug Activity in HCC Supports Further Exploration of IL-27 as a Treatment Target.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 38
- By:
- Publication type:
- Article
12
OncLive Honors 13 Cancer Care Pioneers.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 27
- Publication type:
- Article
13
Multidisciplinary Collaboration Is Essential in Early-Stage NSCLC.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 18
- By:
- Publication type:
- Article
14
Expanded FDA Approval Broadens Role of Lutetium Lu 177 Vipivotide Tetraxetan in PSMA+ mCRPC.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 14
- By:
- Publication type:
- Article
15
FDA Digest.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 12
- Publication type:
- Article
16
TWO SIDES OF THE SAME COIN: Clinical Judgment in the Provision of Optimal Care vs Selection Bias in a Survival Analysis.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 10
- By:
- Publication type:
- Article
17
OncologyLive Honors 13th Annual Giants of Cancer Care® Winners.
- Published in:
- OncologyLive, 2025, v. 26, n. 6, p. 8
- By:
- Publication type:
- Article